# Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes

> **NCT01394510** · NA · COMPLETED · sponsor: **Utzschneider, Kristina, M.D.** · enrollment: 13 (actual)

## Conditions studied

- Type 2 Diabetes
- Oxidative Stress

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT01394510
- **Lead sponsor:** Utzschneider, Kristina, M.D.
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-09
- **Final completion:** 2015-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394510, "Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01394510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*